KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $22.2 million.

  • Cme's Gains from Investment Securities rose 8655.46% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.5 million, marking a year-over-year increase of 10414.2%. This contributed to the annual value of $33.0 million for FY2024, which is 19593.02% up from last year.
  • According to the latest figures from Q3 2025, Cme's Gains from Investment Securities is $22.2 million, which was up 8655.46% from $600000.0 recorded in Q2 2025.
  • In the past 5 years, Cme's Gains from Investment Securities registered a high of $430.0 million during Q2 2022, and its lowest value of -$451.3 million during Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $4.4 million (2024), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Cme's Gains from Investment Securities surged by 876666.67% in 2021, and later plummeted by 9036000.0% in 2022.
  • Cme's Gains from Investment Securities (Quarter) stood at $500000.0 in 2021, then crashed by 90360.0% to -$451.3 million in 2022, then surged by 97.21% to -$12.6 million in 2023, then soared by 127.78% to $3.5 million in 2024, then surged by 534.29% to $22.2 million in 2025.
  • Its last three reported values are $22.2 million in Q3 2025, $600000.0 for Q2 2025, and $8.2 million during Q1 2025.